Warning: Undefined array key "S1" in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Analgesics agents and analgetic effects.php on line 2
Analgesics agents and analgetic effects
LE WE PMID CA
Analgesics agents and analgetic effects8383Analgetika und analgetische Wirkungen

A425619 ttTRPV1

Analgesics agents and analgetic effects

Antiinflammatory compounds

Arachidonoyl serotonin

Botulinus toxin (Therapeutic use)

Butamben

Cannabidiol

Cannabis

Capsaicin

Fatty acid amide hydrolase

Ion channel (TRP Family)

Laser (Medical aspects)

N Palmitoyl vanillamide palvanil

Nicotine

Pain (Neurophysiology)

Resolvin D1

SNAP25

SR141716 ttCB1

SR144528 ttCB2

Tapentadol

TRPA1

TRPM8

TRPV1

TRPV2

TRPV3

TRPV4

URB597 ttFAAH

2011  
1
2010  
2
The discovery and development of analgesics: new mechanisms, new modalities.
[21041957] J Clin Invest 120(11): 3753-9 (2010)
2008  
3
Calcium-dependent desensitization of vanilloid receptor TRPV1: a mechanism possibly involved in analgesia induced by topical application of capsaicin.
[18481914] Physiol Res 57 Suppl 3(-): S59-68 (2008)
2004  
4
Vanilloid TRPV1 receptor mediates the antihyperalgesic effect of the nonpsychoactive cannabinoid, cannabidiol, in a rat model of acute inflammation.
[15313881] Br J Pharmacol 143(2): 247-50 (2004)
2005  
5
A-425619 [1-isoquinolin-5-yl-3-(4-trifluoromethyl-benzyl)-urea], a novel transient receptor potential type V1 receptor antagonist, relieves pathophysiological pain associated with inflammation and tissue injury in rats.
[15837818] J Pharmacol Exp Ther 314(1): 410-21 (2005)
2011  
6
Novel therapeutics based on recombinant botulinum neurotoxins to normalize the release of transmitters and pain mediators.
[21645262] FEBS J 278(23): 4454-66 (2011)
2012  
7
Palvanil, a non-pungent capsaicin analogue, inhibits inflammatory and neuropathic pain with little effects on bronchopulmonary function and body temperature.
[22634607] Pharmacol Res 66(3): 243-50 (2012)
2010  
8
The dual fatty acid amide hydrolase/TRPV1 blocker, N-arachidonoyl-serotonin, relieves carrageenan-induced inflammation and hyperalgesia in mice.
[20138997] Pharmacol Res 61(6): 537-46 (2010)
2010  
9
Resolvin D1 attenuates activation of sensory transient receptor potential channels leading to multiple anti-nociception.
[20880407] Br J Pharmacol 161(3): 707-20 (2010)
2007  
10
TRP channels: targets for the relief of pain.
[17321113] Biochim Biophys Acta 1772(8): 989-1003 (2007)
2009  
11
TRP channel antagonists for pain--opportunities beyond TRPV1.
[19579171] Curr Opin Investig Drugs 10(7): 655-63 (2009)
2005  
12
Transient receptor potential ion channels as targets for the discovery of pain therapeutics.
[15675603] Curr Opin Investig Drugs 6(1): 48-57 (2005)
2009  
13
2011  
14
Therapeutic targeting of TRP channels--the TR(i)P to pain relief.
[21671881] Curr Top Med Chem 11(17): 2118-30 (2011)
2010  
15
Laser modulation of heat and capsaicin receptor TRPV1 leads to thermal antinociception.
[20935279] J Dent Res 89(12): 1455-60 (2010)
2009  
16
Role of ionotropic cannabinoid receptors in peripheral antinociception and antihyperalgesia.
[19070372] Trends Pharmacol Sci 30(2): 79-84 (2009)
2012  
17
Inhibition of sensory neuronal TRPs contributes to anti-nociception by butamben.
[22133806] Neurosci Lett 506(2): 297-302 (2012)
2011  
18
Tapentadol extended-release for treatment of chronic pain: a review.
[21887118] J Pain Res 4(-): 211-8 (2011)

Downloaded from http://www.kidney.de - The Database of Free Medical Reviews - The Metatextbook of Medicine - Ossip Groth

All Medline data shown were primarily retrieved from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.


Fatal error: Uncaught Error: Call to undefined function mysql_connect() in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Analgesics agents and analgetic effects.php:92 Stack trace: #0 {main} thrown in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Analgesics agents and analgetic effects.php on line 92